CIPLA TADALAFIL 2.5 tadalafil 2.5 mg film-coated tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

tadalafil, Quantity: 2.5 mg

Disponibbli minn:

Cipla Australia Pty Ltd

INN (Isem Internazzjonali):

Tadalafil

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: croscarmellose sodium; hyprolose; magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium lauryl sulfate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

10, 28, 20, 7

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

CIPLA TADALAFIL is indicated for the treatment of: ? erectile dysfunction (ED) in adult males ? moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males

Sommarju tal-prodott:

Visual Identification: Cream coloured, circular, biconvex film coated tablet with "T 2.5" debossed on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2017-03-27